| In millions, except per share items | Jan-02-16 | Jan-03-15 | Dec-28-13 | Dec-29-12 | Dec-31-11 | Jan-01-11 | Jan-02-10 | Jan-03-09 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K |
| Revenues: |
| Photonics | 249.3 | 245.7 | 230.3 | 237.6 | 204.3 | | | |
| United States | 231.5 | 230.8 | 218.3 | 243.7 | 240.7 | 233.5 | 169.9 | 208.7 |
| Lasers | 192.8 | 193.0 | 165.8 | 181.4 | 191.5 | 182.1 | 147.3 | 187.5 |
| Optics | 160.6 | 166.4 | 164.0 | 176.3 | 149.2 | | | |
| Other | | | | | | 64.2 | 49.7 | 49.1 |
| Total revenues | 602.7 | 605.2 | 560.1 | 595.3 | 545.1 | 479.8 | 367.0 | 445.3 |
| Revenue growth [+] | -0.4% | 8.1% | -5.9% | 9.2% | 13.6% | 30.7% | -17.6% | 0.0% |
| Photonics | 1.5% | 6.7% | -3.1% | 16.3% | | | | |
| United States | 0.3% | 5.7% | -10.4% | 1.2% | 3.1% | 37.4% | -18.6% | |
| Lasers | -0.1% | 16.4% | -8.6% | -5.3% | 5.2% | 23.6% | -21.4% | 1.3% |
| Optics | -3.5% | 1.5% | -7.0% | 18.2% | | | | |
| Other Pacific Rim countries | -2.1% | 6.1% | 7.8% | 16.8% | 23.3% | | | |
| Cost of goods sold | 340.2 | 334.4 | 322.3 | 334.8 | 305.3 | 274.5 | 224.4 | 274.5 |
| Gross profit | 262.5 | 270.8 | 237.7 | 260.6 | 239.7 | 205.3 | 142.6 | 170.8 |
| Gross margin | 43.6% | 44.7% | 42.4% | 43.8% | 44.0% | 42.8% | 38.9% | 38.4% |
| Selling, general and administrative | 155.5 | 158.6 | 149.2 | 159.3 | 140.6 | 112.8 | 112.2 | 118.5 |
| Research and development | 58.5 | 58.4 | 52.5 | 52.7 | 45.3 | 39.3 | 36.9 | 46.1 |
| Other operating expenses | | | | -0.2 | | 0.5 | 4.7 | -2.5 |
| EBITDA [+] | 76.8 | 81.8 | 66.5 | 88.3 | 77.8 | 71.4 | 8.7 | 30.6 |
| EBITDA growth | -6.1% | 23.1% | -24.7% | 13.5% | 9.0% | 721.1% | -71.6% | -35.6% |
| EBITDA margin | 12.7% | 13.5% | 11.9% | 14.8% | 14.3% | 14.9% | 2.4% | 6.9% |
| Depreciation | 20.0 | 19.3 | 20.2 | 21.9 | 16.3 | 15.5 | 19.9 | 21.9 |
| EBITA | 56.9 | 62.5 | 46.3 | 66.4 | 61.5 | 55.9 | -11.2 | 8.7 |
| EBITA margin | 9.4% | 10.3% | 8.3% | 11.2% | 11.3% | 11.7% | -3.1% | 2.0% |
| Amortization of intangibles | 8.4 | 8.8 | 10.3 | 17.7 | 7.7 | 3.2 | | |
| EBIT [+] | 48.5 | 53.7 | 36.0 | 48.7 | 53.8 | 52.7 | -11.2 | 8.7 |
| EBIT growth | -9.7% | 49.1% | -26.1% | -9.5% | 2.1% | -569.1% | -229.0% | -67.1% |
| EBIT margin | 8.0% | 8.9% | 6.4% | 8.2% | 9.9% | 11.0% | -3.1% | 2.0% |
| Non-recurring items [+] | 1.1 | 1.9 | 4.7 | 130.9 | | | | 119.9 |
| Asset impairment | | | | 130.9 | | | 0.4 | 119.9 |
| Loss (gain) on sale of assets | 1.1 | 1.9 | 4.7 | | | | 4.4 | |
| Interest expense | 2.3 | 2.4 | 5.5 | | | | | |
| Interest expense | 2.3 | 2.4 | 5.5 | 8.2 | 10.6 | 8.3 | | |
| Other income (expense), net [+] | -2.0 | -1.7 | -4.4 | 5.9 | 7.3 | -0.2 | -8.1 | -8.9 |
| Asset impairment charges | | | | | | | 0.4 | |
| Gain (loss) on sale of assets | | | | 6.2 | | | 4.4 | |
| Gain (loss) on sale of business | | | | -0.2 | | 0.5 | | |
| Gain (loss) on debt retirement | | | -3.4 | | -0.6 | | 0.3 | 7.7 |
| Other | -2.0 | -1.7 | -1.0 | -8.6 | -10.6 | -8.5 | -8.6 | |
| Pre-tax income | 43.1 | 47.7 | 21.4 | -84.5 | 50.5 | 44.2 | -19.4 | -120.2 |
| Income taxes | 11.9 | 12.5 | 5.7 | 5.5 | -29.2 | 3.1 | -2.0 | 28.5 |
| Tax rate | 27.7% | 26.2% | 26.6% | | | 7.1% | 10.2% | |
| Minority interest | | 0.1 | 0.1 | -0.5 | 0.0 | | | |
| Net income | 31.1 | 35.1 | 15.6 | -89.4 | 79.7 | 41.1 | -17.4 | -148.7 |
| Net margin | 5.2% | 5.8% | 2.8% | -15.0% | 14.6% | 8.6% | -4.7% | -33.4% |
| |
| Basic EPS [+] | $0.79 | $0.88 | $0.40 | ($2.35) | $2.13 | $1.12 | ($0.48) | ($4.11) |
| Growth | -10.0% | 120.5% | -117.1% | -210.1% | 89.9% | -333.2% | -88.3% | -498.8% |
| Diluted EPS [+] | $0.78 | $0.87 | $0.39 | ($2.35) | $2.06 | $1.09 | ($0.48) | ($4.11) |
| Growth | -9.7% | 119.3% | -116.8% | -213.8% | 89.1% | -326.5% | -88.3% | -504.8% |
| |
| |
| Shares outstanding (basic) [+] | 39.2 | 39.8 | 39.0 | 38.1 | 37.4 | 36.6 | 36.2 | 36.2 |
| Growth | -1.3% | 1.9% | 2.3% | 1.9% | 2.1% | 1.3% | 0.1% | -6.0% |
| Shares outstanding (diluted) [+] | 39.8 | 40.5 | 39.6 | 38.1 | 38.7 | 37.7 | 36.2 | 36.2 |
| Growth | -1.7% | 2.5% | 3.7% | -1.4% | 2.5% | 4.3% | 0.1% | -7.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |